| Heroes Better Positioned Than Many Americans to Achieve Homeownership, New Homes for Heroes Research Finds |
Globe Newswire |
07/30 |
08:00 |
| ZenaTech's DaaS Oil and Gas Business Enters a Strengthened Market with Higher Oil Prices and More Than US$500 Billion in Expected Canadian Energy Investment Over the Next Decade |
Globe Newswire |
07/30 |
08:00 |
| Aureus Greenway Holdings Inc. and Autonomous Power Corporation (dba Powerus) Announce Public Filing of Form S-4 Registration Statement with the SEC |
Globe Newswire |
07/30 |
08:00 |
| Euronet Worldwide Reports Second Quarter 2026 Financial Results |
Globe Newswire |
07/30 |
08:00 |
| ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026 |
Globe Newswire |
07/30 |
08:00 |
| Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference |
Globe Newswire |
07/30 |
08:00 |
| Colossal Raises $6.8M to Support The Art of Elysium, Reveals Inaugural People's Artist Winner |
Globe Newswire |
07/30 |
08:00 |
| Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin |
Globe Newswire |
07/30 |
08:00 |
| Diginex Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement |
Globe Newswire |
07/30 |
08:00 |
| License Global Releases 2026 Top Global Licensors Whitepaper, Featuring Disney, Authentic Brands Group, People Inc. |
Globe Newswire |
07/30 |
08:00 |
| Beyond Oil Expands Commercial Rollout to a Second Ownership Group of Top-Tier U.S. Supermarket Brand |
Globe Newswire |
07/30 |
08:00 |
| PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026 |
Globe Newswire |
07/30 |
08:00 |
| Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026 |
Globe Newswire |
07/30 |
08:00 |
| Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026 |
Globe Newswire |
07/30 |
08:00 |
| Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026 |
Globe Newswire |
07/30 |
08:00 |
| Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June |
Globe Newswire |
07/30 |
08:00 |
| Harsco Environmental Recognized in Three Newsweek America’s Greatest Workplaces Awards |
Globe Newswire |
07/30 |
08:00 |
| Capital IP Investment Partners Announces Strategic Investment in Minno |
Globe Newswire |
07/30 |
08:00 |
| Carpenter Technology Reports Fourth Quarter and Fiscal Year 2026 Results |
Globe Newswire |
07/30 |
08:00 |
| Uniti Group Inc. Reports Second Quarter 2026 Results |
Globe Newswire |
07/30 |
08:00 |
| Stride Announces CEO Succession |
Globe Newswire |
07/30 |
08:00 |
| Oyster Creek’s License Termination Plan Approved by the USNRC; Oyster Creek Project Planned to Feature Four SMR-300 Units |
Globe Newswire |
07/30 |
08:00 |
| Jeen Launches "AI on Your Terms" to Help Enterprise Leaders Ask the Questions Most AI Programmes Skip |
Globe Newswire |
07/30 |
08:00 |
| CorVascular Launches ASUS Handheld Ultrasound Portfolio for Vascular Specialists at SVU 2026 |
Globe Newswire |
07/30 |
08:00 |
| Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
07/30 |
08:00 |
